Interim Results Indicate Positive Efficacy Trends in FDA-Approved Phase I Clinical Stem Cell Trial For Patients with Multiple Sclerosis
The Tisch MS Research Center of New York is dedicated to finding the cause of and cure for multiple sclerosis
Tisch MS News
This week eight of Tisch MSRCNY’s researchers arrived in Washington, D.C. to attend the 67th American Academy of Neurology Annual Meeting. Eight of the Center’s Abstracts will be presented at the meeting. Dr. Sadiq was also informed on Monday that the preliminary results from our FDA-approved Phase 1 clinical stem cell trial for patients with MS were selected as a presentation during the Multiple Sclerosis Highlights in the Field session on Wednesday, April 22nd...